drugset
drugset / Trial / NCT07713758

A Trial to Examine if Repinatrabit is Processed Differently in Adults With Reduced Liver or Kidney Function Compared to Adults With Normal Liver and Kidney Function

NCT07713758 ↗

Phase 1 Not yet recruiting 32 enrolled Otsuka Pharmaceutical Development & Commercialization, Inc.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This trial is intended to understand how the body processes repinatrabit in people with moderate liver impairment and severe kidney impairment and also to compare these results with people of similar age, weight, and sex who have normal liver function.

Timeline

Start
2026-07-17
Primary completion
2027-02-09
Completion
2027-02-15

Drugs

EvaluationDrugModalityDoseRoute
Subject JNT-517 Unknown — Oral

Indications

phenylketonuria